Artery disease – From basic biological research through better understanding to improved prevention and treatment Time Monday 7/4 2014 (General frame and.

Slides:



Advertisements
Similar presentations
TWO STEP EQUATIONS 1. SOLVE FOR X 2. DO THE ADDITION STEP FIRST
Advertisements

Egyptian Perspective On Prediabetes & Diabetes
Slide 1 Insert your own content. Slide 2 Insert your own content.
SORT-OUT III: A Prospective Randomized Comparison of Zotarolimus-Eluting and Sirolimus-Eluting Stents in Patients with Coronary Artery Disease Michael.
1 Copyright © 2010, Elsevier Inc. All rights Reserved Fig 2.1 Chapter 2.
1 Chapter 40 - Physiology and Pathophysiology of Diuretic Action Copyright © 2013 Elsevier Inc. All rights reserved.
By D. Fisher Geometric Transformations. Reflection, Rotation, or Translation 1.
Combining Like Terms. Only combine terms that are exactly the same!! Whats the same mean? –If numbers have a variable, then you can combine only ones.
0 - 0.
1  1 =.
2 pt 3 pt 4 pt 5 pt 1 pt 2 pt 3 pt 4 pt 5 pt 1 pt 2 pt 3 pt 4 pt 5 pt 1 pt 2 pt 3 pt 4 pt 5 pt 1 pt 2 pt 3 pt 4 pt 5 pt 1 pt Time Money AdditionSubtraction.
ALGEBRAIC EXPRESSIONS
DIVIDING INTEGERS 1. IF THE SIGNS ARE THE SAME THE ANSWER IS POSITIVE 2. IF THE SIGNS ARE DIFFERENT THE ANSWER IS NEGATIVE.
ADDING INTEGERS 1. POS. + POS. = POS. 2. NEG. + NEG. = NEG. 3. POS. + NEG. OR NEG. + POS. SUBTRACT TAKE SIGN OF BIGGER ABSOLUTE VALUE.
MULTIPLICATION EQUATIONS 1. SOLVE FOR X 3. WHAT EVER YOU DO TO ONE SIDE YOU HAVE TO DO TO THE OTHER 2. DIVIDE BY THE NUMBER IN FRONT OF THE VARIABLE.
SUBTRACTING INTEGERS 1. CHANGE THE SUBTRACTION SIGN TO ADDITION
MULT. INTEGERS 1. IF THE SIGNS ARE THE SAME THE ANSWER IS POSITIVE 2. IF THE SIGNS ARE DIFFERENT THE ANSWER IS NEGATIVE.
Addition Facts
SVQs Business and Administration Launch Events January/February 2011.
Remodelage et plaque dathérome: intérêt des IEC à forte dose G. Derumeaux Lyon Conflit d'intérêt : Servier, Actelion, Sanofi-Aventis.
YEAR 1 WEEK 15 CAREER DEVELOPMENT WORKSHOP DAY 1 delivered by Careers Service/JFR 10:00welcome and introduction 10:30considering the options - roles, careers,
Show Order 2 Shows 8:00 – 10:30 Weigh in 11:00 Ewes – by Weight Champion Ewe Market Classes (Hamp) Champion Drive 1:00 – 2:30 Weigh in 2 nd show (approximate.
O X Click on Number next to person for a question.
© S Haughton more than 3?
Effects on UK of Eustatic sea Level rise GIS is used to evaluate flood risk. Insurance companies use GIS models to assess likely impact and consequently.
1 Directed Depth First Search Adjacency Lists A: F G B: A H C: A D D: C F E: C D G F: E: G: : H: B: I: H: F A B C G D E H I.
1 Problem based Learning in Engineering and Science – Development of Facilitator A Course given by: Xiangyun Du Department of Education, Learning and Philosophy.
1 Problem based Learning in Engineering and Science – Development of Facilitator A Course given by: Mona Dahms Department of Development and Planning Vestre.
Linking Verb? Action Verb or. Question 1 Define the term: action verb.
”Towards further strengthening the cooperation between AK and partners in South” Sunday, 27th November Wednesday, 30th November 2011 AK Partnership.
Vascular cognitive impairment – an overview
NiGP Network Meeting Day 1 - Monday 25 th May 2009.
Past Tense Probe. Past Tense Probe Past Tense Probe – Practice 1.
Properties of Exponents
Addition 1’s to 20.
25 seconds left…...
Blood Flow and the Control of Blood Pressure
Test B, 100 Subtraction Facts
Doubles Facts Doubles with Pictures Doubles without Pictures Pictures Only.
35th International IGIP Symposium, 2006, Tallinn, Estonia Problem based Learning in Engineering and Science – Development of Facilitator 1 Mona Dahms Department.
Professor Michael Hecht Olsen Appointment Symposium January 18th Conference Auditorium U100, Main Entrance University of Southern Denmark Campusvej.
11 = This is the fact family. You say: 8+3=11 and 3+8=11
Week 1.
Conference Program 09:00 Welcome 09:30 Session 1: Optics and Photonics 10:45 Coffee Break (Poster Session) 11:15 Session 2: Gravitation, Cosmology and.
Blood Flow and the Control of Blood Pressure
Chapter 15b Blood Flow and the Control of Blood Pressure.
O X Click on Number next to person for a question.
SORT-OUT III: A Prospective Randomized Comparison of Zotarolimus-Eluting and Sirolimus-Eluting Stents in Patients with Coronary Artery Disease Jens Flensted.
BY Dr. Khaled Helmy Al Mahmora Chest Hospital BY Dr. Khaled Helmy Al Mahmora Chest Hospital Treatment Of Hypertension In Diabetes.
Let’s go to school in Reims! Programme of the mobility May 11th -16th 2014.
CKD in individuals with CKD
Stents Are Not Enough: Statins Keith Channon Department of Cardiovascular Medicine University of Oxford John Radcliffe Hospital, Oxford.
Assessment Statements H.5.1 Explain the events of the cardiac cycle, including atrial and ventricular systole and diastole, and heart sounds. H.5.2 Analyse.
Atherosclerosis Hisham Al Khalidi. Vessel wall structure.
AHA- Nov 12, 2005, Dallas P.K.Shah, MD Director of Cardiology and Atherosclerosis Research Center, Cedars-Sinai Medical Center, Professor of Medicine,
Anatomy and physiology of t2d Lesson Five Today we will… Make a human body poster that shows how t2d affects organs and body systems Look at treatment.
Plasminogen-Activating Inhibitor-1 (PAI-1) High PAI-1 associated with: Obesity (especially visceral), possible fatty liver. 2,3,4 Inflammation and oxidative.
Remodelling Ability of living tissue to adapt to its environment by changing its shape and structure Modifies mechanical properties Driven by tendency.
Insulin Resistance Progression to Diabetes. Hypertension: BP >140/90 Dyslipidemia: ◦TG >150 mg/dL (1.7 mmol.L) ◦HDL-C
Ischemic Heart Disease Dr. Ravi Kant Assistant Professor Department of General Medicine.
1 Mathematical modeling of blood flow in translational medicine (1) Moscow Institute of Physics and Technology (2) Institute of Numerical Mathematics Workgroup.
Diabetes: Beyond Sugar. CHAOS C - Coronary artery disease H - Hyper-tension, -glycaemia, -insulinaemia A - Atherosclerosis O - Obesity S - Stroke.
Can osteoprotegerin be used to identify the presence and severity of coronary artery disease in different clinical settings?  Susanne Elisabeth Hosbond,
Soluble urokinase plasminogen activator receptor is in contrast to high-sensitive C- reactive-protein associated with coronary artery calcifications in.
Heart Health & Diabetes
What do I know? What is an electrocardiogram?
Artery disease – From basic biological research through better understanding to improved prevention and treatment Time Monday 7/ (General frame and.
Professor MH. Olsen inaugural seminar 3/
SORT-OUT III: A Prospective Randomized Comparison of Zotarolimus-Eluting and Sirolimus-Eluting Stents in Patients with Coronary Artery Disease Michael.
Your Task With your partner, research and design an interactive presentation on one of the assigned heart diseases. Your presentation must include the.
Presentation transcript:

Artery disease – From basic biological research through better understanding to improved prevention and treatment Time Monday 7/ (General frame and definitions) Thuesday 8/4 Atherosclerosis and large arteries) Arteriosclerosis and large arteries + Remodeling and small arteries 10/4 Remodeling and small arteries + Global approach 8.45 Meeting at Research and Education Program for Heart, Kidney and Circulation ( ) Biochemical markers of arterial disease - Lars Melholt Rasmussen Impedance cardiography, HOTMAN system – FM Fadl Elmula, Oslo Endothelin and human pericardial arteries as model - Jo De Mey Coronary IVUS and OCT Lisbeth Antonsen Diabetic arteriopathy Lars Melholt Rasmussen Vital microscopy analyses of extracellular matrix–M.Bloksgård Welcome ( ) MHO/Lars Melholt Rasmussen Coronary CT Axel Diederichsen The forearm model for human vessels. Helena Dominquez, KU Prostaglandins + atherosclerosis – murine models - Jane Stubbe Arterial Aging Peter Nilsson, Lund U Coronary PET/CT Poul Flemming Højlund-Carlsen Vascular changes in diabetes Thomas Ledet, AU Calcium channels in resistance vessels - Pernille BL Hansen Translational cardiometabolic research - Olle Melander, Lund U Aorta aneurismsAAA:Epidemiology, development, treatment-J Lindholt The complement in microvascular changes in DM-Jakob Østergaard,AU Cl-channels and resistance artery function - Vladimir Matchkov, AU Arterial signaling - Niels-Henrik Holstein-Rathlou, KU AAA: Patoanatomy, -physiology, experimental studies - Jes Lindholt Macro- microvascular crosstalk in diabetes. Esben Laugesen, AU Vascular pH –hypertension - new mechanism (Ebbe Boedtkjer),AU Lunch Structural changes – large arteries (hypertrofic) Stephane Laurent Moderated Posters 8 x (3+2) min. Social event Prevention and Risk stratification Michael Hecht Olsen Functional changes – large arteries (arteriosclerosis) Stephane Laurent Chronotherapy in hypertension and T2DM - Niklas B. Rossen, AU Moderated Posters 8 x (3+2) min. Structural changes – small arteries Jo De Mey Individualized arterial medicine - Ulrike Steckelings/Jo De Mey Endothelial dysfuction - Myogenic tone Christian Aalkjær, AU Arterial changes in chronic kidney disease - Susanne Bro, KU Moderated Posters 8 x (3+2) min. Individualized treatment in Hypertension - Stephane Laurent Atherosclerosis Jacob Fog Bentzon, AU Hypertrophy of large arteries Stephane Laurent, Paris Individualized treatment in T2DM Henning Beck-Nielsen Moderated Posters 8 x (3+2) min. Matricellular proteins and neointimal hyperplasia - Murine - Grith Sørensen Stiffness of large arteries Stephane Laurent, Paris Future individualized treatment MHO/Lars Melholt Rasmussen Biomarkers of atherosclerosis Jacob Fog Bentzon, AU Endothelial function assessment Trine K. Sønder, Gent Resistance arteries in human hypertension Kent L. Christensen,KU Course evaluation MHO/Lars Melholt Rasmussen Carotid plaque composition by MR and T2DM - Pernille Høyem, AU Ventriculo-arterial coupling Trine K. Sønder, Gent Coronary flow reserve Kent Lodberg Christensen, KU UL carotis /SphygmoCor demo Sara V. Greve/Trine K. Sønder UL carotis /SphygmoCor demo Sara V. Greve/Trine K. Sønder MFVR/HOTMAN system demo Ole Mathiasen/FM Fadl Elmula, Oslo